Page last updated: 2024-08-21

aflatoxin b1 and cyclosporine

aflatoxin b1 has been researched along with cyclosporine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Arefolov, A; Clardy, J; Clarke, AS; Ishihara, K; Marks, KM; Park, ES; Pelish, HE; Ring, JE; Russo, K1
Carpi, D; Lloyd, GR; Malinowska, JM; Palosaari, T; Sund, J; Viant, MR; Weber, RJM; Whelan, M1

Other Studies

4 other study(ies) available for aflatoxin b1 and cyclosporine

ArticleYear
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
The selectivity of austocystin D arises from cell-line-specific drug activation by cytochrome P450 enzymes.
    Journal of natural products, 2011, Apr-25, Volume: 74, Issue:4

    Topics: Aflatoxin B1; Aflatoxins; Antineoplastic Agents; Aspergillus; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Cytochrome P-450 Enzyme System; DNA Damage; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Humans; Molecular Structure

2011
Derivation of metabolic point of departure using high-throughput in vitro metabolomics: investigating the importance of sampling time points on benchmark concentration values in the HepaRG cell line.
    Archives of toxicology, 2023, Volume: 97, Issue:3

    Topics: Aflatoxin B1; Benchmarking; Benzo(a)pyrene; Cell Line; Cyclosporine; Lipids; Metabolomics; Rotenone

2023